MetaADEDB 2.0 @ LMMD
temocapril hydrochloride
(FIQOFIRCTOWDOW-BJLQDIEVSA-N)
Structure
SMILES
CCOC(=O)[C@@H](N[C@H]1CS[C@@H](CN(C1=O)CC(=O)O)c1cccs1)CCc1ccccc1
Type(s)
Experimental; Investigational
ATC code(s)
C09AA14
Molecular Formula:
C23H28N2O5S2
Molecular Weight:
476.609
Log P:
3.3007
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
2
TPSA:
149.48
CAS Number(s):
111902-57-9
Synonym(s)
1.
temocapril hydrochloride
2.
CS 622
3.
CS-622
4.
CS622
5.
alpha-((2S,6R)-6-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino-5-oxo-2-(2-thienyl)perhydro-1,4-thiazepin-4-yl)acetic acid.HCl
6.
temocapril
External Link(s)
MeSHC055603
PubChem Compound40466973
443874
ChEBI135771
CHEMBLCHEMBL2110627
DrugBankDB08836
DrugCentral2586
KEGGdr:D08566
ZINC3808778
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisOFFSIDES
2Activities of daily living impairedOFFSIDES
3Acute intermittent porphyriaOFFSIDES
4Acute prerenal failureOFFSIDES
5AgraphiaOFFSIDES
6Altered state of consciousnessOFFSIDES
7AneurysmOFFSIDES
8AnhidrosisOFFSIDES
9AnorexiaOFFSIDES
10Anti-insulin antibody positiveOFFSIDES
11AnuriaOFFSIDES
12Aortic AneurysmOFFSIDES
13ApathyOFFSIDES
14Blood GlucoseOFFSIDES
15Blood alkaline phosphatase increasedOFFSIDES
16Blood calcium abnormalOFFSIDES
17Blood chloride decreasedOFFSIDES
18Blood creatinine increasedOFFSIDES
19Blood fibrinogen increasedOFFSIDES
20Blood glucose decreasedOFFSIDES
21Blood glucose fluctuationOFFSIDES
22Blood lactate dehydrogenase increasedOFFSIDES
23Blood phosphorus increasedOFFSIDES
24Blood potassium increasedOFFSIDES
25Blood pressure inadequately controlledOFFSIDES
26Blood sodiumOFFSIDES
27Blood triglycerides decreasedOFFSIDES
28Blood urea increasedOFFSIDES
29ColitisOFFSIDES
30Conversion disorderOFFSIDES
31Depressed Level of ConsciousnessOFFSIDES
32Detachment of retinal pigment epitheliumOFFSIDES
33Diabetic NephropathyOFFSIDES
34Disseminated Intravascular CoagulationOFFSIDES
35DiverticulosisOFFSIDES
36Dry skinOFFSIDES
37DyscheziaOFFSIDES
38DysuriaOFFSIDES
39Erythema MultiformeOFFSIDES
40Focal glomerulosclerosisOFFSIDES
41Gastrointestinal erosionOFFSIDES
42Gingival HypertrophyOFFSIDES
43GingivectomyOFFSIDES
44GlobulinuriaOFFSIDES
45Hallucinations, mixedOFFSIDES
46HemiplegiaOFFSIDES
47Histiocytosis haematophagicOFFSIDES
48Immune reconstitution syndromeOFFSIDES
49InfectionOFFSIDES
50Injection site dermatitisOFFSIDES
51Intestinal ObstructionOFFSIDES
52Intestinal PerforationOFFSIDES
53Leukopenia neonatalOFFSIDES
54Lymphangiosis carcinomatosaOFFSIDES
55Lymphocyte stimulation test positiveOFFSIDES
56MalabsorptionOFFSIDES
57Metabolic acidosisOFFSIDES
58Myoglobin blood increasedOFFSIDES
59Nephrotic SyndromeOFFSIDES
60OliguriaOFFSIDES
61Oropharyngitis fungalOFFSIDES
62OverdoseOFFSIDES
63ParaparesisOFFSIDES
64Pelvic fluid collectionOFFSIDES
65PericoronitisOFFSIDES
66PeritonitisOFFSIDES
67Post procedural complicationOFFSIDES
68Psychiatric symptomOFFSIDES
69PyelonephritisOFFSIDES
70Retinal Vein OcclusionOFFSIDES
71Retinal pigment epithelial tearOFFSIDES
72RhabdomyolysisOFFSIDES
73Silent myocardial infarctionOFFSIDES
74Skin lesionOFFSIDES
75SpondylitisOFFSIDES
76Thrombotic strokeOFFSIDES
77Traumatic fractureOFFSIDES
78Vitamin K DeficiencyOFFSIDES
79Weight GainOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.